Molecular Cytogenetics Market by Technology (Array-Comparative Genomic Hybridization, Fluorescence In Situ Hybridization), and Applications (Cancer, Genetic Disorders, Personalized Medicines, Neurological, Cardiovascular and Infectious Diseases) and Forecast 2017-2021

Molecular Cytogenetics Market by Technology (Array-Comparative Genomic Hybridization, Fluorescence In Situ Hybridization), and Applications (Cancer, Genetic Disorders, Personalized Medicines, Neurological, Cardiovascular and Infectious Diseases) and Forecast 2017-2021

Molecular biological techniques are at the forefront as they have the advantage of providing a combined research of molecular as well as cytological approach. Introduction of fluorescence in situ hybridization (FISH) and array-comparative genomic hybridization (aCGH) technologies have contributed significantly to the molecular cytogenetics market in the diagnostics and research sectors. FISH and aCGH diagnostic techniques are considered as excellent diagnostic tools because of their ability to provide accurate diagnosis in a short span of time. Cytogenetic analyses are considered mandatory part for leukemia diagnosis. Introduction of advanced technologies enable healthcare professionals in detecting chromosomal abnormalities and hidden chromosome aberrations in patients. FISH has provided significant advances in both research and diagnosis of genetic abnormalities, hematological malignancies and solid tumors. aCGH is preferred over other techniques due to its ability to detect deletion, duplication or amplification at a sub-microscopic level. Globally rising number of cancer cases, genetic disorders, hematological malignancies and technological advancements are some of the factors contributing to the global molecular cytogenetics market.

The global molecular cytogenetics market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).

The global molecular cytogenetics market segmentation is based on technology (array-comparative genomic hybridization, fluorescence in situ hybridization), and applications (cancer, genetic disorders, personalized medicines, neurological, cardiovascular and infectious diseases).

The global molecular cytogenetics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global molecular cytogenetics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global molecular cytogenetics market and included in this report are Abbott Molecular Inc., Applied Spectral Imaging, Inc., Illumina Inc., Life Technologies Corporation, Cytognomix, Inc. and others.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Products
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Product Type (cells, media, serum, vaccine, protein, instrument, etc.)
    • Source Type
    • Reagents and Consumables Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  8. Recommendations
  9. References

Molecular Cytogenetics Market

1. Technology
1.1. Array-Comparative Genomic Hybridization (aCGH)
1.2. Fluorescence in situ hybridization (FISH)

2. Application
2.1. Cancer
2.2. Genetic Disorders
2.3. Personalized Medicines
2.4. Others (Neurological, Cardiovascular and Infectious Diseases, etc.)

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World

4. Company Profiles
4.1. Abbott Laboratories
4.2. Affymetrix, Inc.
4.3. Agilent Technologies, Inc.
4.4. Applied Spectral Imaging, Inc.
4.5. BI Biological Industries
4.6. Bio-Rad Laboratories
4.7. CytoTest Inc.
4.8. Cytognomix, Inc.
4.9. F. Hoffmann-La Roche Ltd.
4.10. Illumina Inc.
4.11. LEICA BIOSYSTEMS
4.12. Life Technologies Corporation
4.13. Oxford Gene Technology
4.14. PerkinElmer, Inc.
4.15. SciGene Corporation

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*